Squarepoint’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $34.3M | Buy |
69,837
+59,825
| +598% | +$32.5M | 0.04% | 466 |
|
|
2025
Q4 | $5.8M | Sell |
10,012
-52,888
| -84% | -$29.9M | 0.01% | 1365 |
|
|
2025
Q3 | $30.5M | Sell |
62,900
-347,001
| -85% | -$162M | 0.03% | 563 |
|
|
2025
Q2 | $166M | Buy |
409,901
+259,423
| +172% | +$108M | 0.17% | 105 |
|
|
2025
Q1 | $74.9M | Buy |
150,478
+97,387
| +183% | +$52.7M | 0.09% | 225 |
|
|
2024
Q4 | $27.6M | Sell |
53,091
-25,800
| -33% | -$14.2M | 0.03% | 607 |
|
|
2024
Q3 | $48.8M | Sell |
78,891
-48,574
| -38% | -$28.8M | 0.08% | 246 |
|
|
2024
Q2 | $70.5M | Buy |
127,465
+107,213
| +529% | +$61.4M | 0.12% | 163 |
|
|
2024
Q1 | $11.8M | Sell |
20,252
-69,689
| -77% | -$39.1M | 0.02% | 894 |
|
|
2023
Q4 | $47.7M | Buy |
89,941
+35,739
| +66% | +$17.3M | 0.09% | 242 |
|
|
2023
Q3 | $27.4M | Sell |
54,202
-21,777
| -29% | -$11.6M | 0.07% | 331 |
|
|
2023
Q2 | $39.6M | Buy |
75,979
+70,592
| +1,310% | +$38.1M | 0.12% | 181 |
|
|
2023
Q1 | $3.1M | Sell |
5,387
-84,465
| -94% | -$47.6M | 0.01% | 1142 |
|
|
2022
Q4 | $49.5M | Buy |
89,852
+86,409
| +2,510% | +$45.8M | 0.2% | 87 |
|
|
2022
Q3 | $1.75M | Buy |
+3,443
| New | +$1.93M | 0.01% | 1406 |
|
|
2022
Q1 | – | Sell |
-11,193
| Closed | -$6.43M | – | 3528 |
|
|
2021
Q4 | $7.47M | Buy |
11,193
+3,519
| +46% | +$2.2M | 0.02% | 641 |
|
|
2021
Q3 | $4.38M | Sell |
7,674
-66,254
| -90% | -$36.4M | 0.01% | 840 |
|
|
2021
Q2 | $37.3M | Sell |
73,928
-46,039
| -38% | -$21.7M | 0.14% | 140 |
|
|
2021
Q1 | $54.8M | Buy |
119,967
+50,558
| +73% | +$24.1M | 0.32% | 39 |
|
|
2020
Q4 | $32.3M | Buy |
+69,409
| New | +$32.5M | 0.24% | 61 |
|
|
2019
Q4 | – | Sell |
-15,100
| Closed | -$4.4M | – | 2805 |
|
|
2019
Q3 | $4.4M | Sell |
15,100
-46,504
| -75% | -$13.3M | 0.04% | 523 |
|
|
2019
Q2 | $18.1M | Buy |
+61,604
| New | +$17M | 0.18% | 133 |
|
|
2019
Q1 | – | Sell |
-43,649
| Closed | -$9.77M | – | 2439 |
|
|
2018
Q4 | $9.77M | Buy |
43,649
+16,822
| +63% | +$3.95M | 0.11% | 229 |
|
|
2018
Q3 | $6.55M | Sell |
26,827
-43,253
| -62% | -$9.95M | 0.08% | 325 |
|
|
2018
Q2 | $14.5M | Buy |
70,080
+65,243
| +1,349% | +$13.8M | 0.19% | 142 |
|
|
2018
Q1 | $999K | Buy |
4,837
+2,898
| +149% | +$608K | 0.02% | 811 |
|
|
2017
Q4 | $368K | Sell |
1,939
-14,361
| -88% | -$2.75M | 0.01% | 1378 |
|
|
2017
Q3 | $3.08M | Sell |
16,300
-209,531
| -93% | -$37.9M | 0.06% | 396 |
|
|
2017
Q2 | $39.4M | Buy |
225,831
+114,825
| +103% | +$19.3M | 0.78% | 11 |
|
|
2017
Q1 | $17.1M | Buy |
111,006
+74,205
| +202% | +$11.3M | 0.47% | 35 |
|
|
2016
Q4 | $5.19M | Buy |
+36,801
| New | +$5.43M | 0.21% | 103 |
|
|
2016
Q3 | – | Sell |
-7,729
| Closed | -$1.14M | – | 1255 |
|
|
2016
Q2 | $1.14M | Sell |
7,729
-1,109
| -13% | -$164K | 0.07% | 314 |
|
|
2016
Q1 | $1.25M | Buy |
+8,838
| New | +$1.18M | 0.1% | 304 |
|
|
2015
Q3 | – | Sell |
-7,081
| Closed | -$919K | – | 578 |
|
|
2015
Q2 | $919K | Buy |
+7,081
| New | +$923K | 0.3% | 97 |
|
Other funds holding TMO
VCM
Squarepoint's TMO Position: Q1 2026 in Review
Squarepoint increased its Thermo Fisher Scientific (TMO) stake by 598% in Q1 2026, buying an estimated $32.5M and bringing the position to 69,837 shares worth $34.3M. The position accounts for 0.04% of the portfolio, ranked #466.
Squarepoint first reported a position in TMO in Q2 2015 and has held it in 34 quarters since. The position peaked at $166M in Q2 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Squarepoint held 69,837 shares of Thermo Fisher Scientific worth $34.3M as of Q1 2026.
- Squarepoint bought 59,825 Thermo Fisher Scientific shares in Q1 2026, an estimated $32.5M.
- Thermo Fisher Scientific made up 0.04% of Squarepoint's portfolio in Q1 2026, its #466 holding.
- Squarepoint first reported a position in Thermo Fisher Scientific in Q2 2015 and has held it in 34 quarters since.
- Squarepoint's Thermo Fisher Scientific position peaked at $166M in Q2 2025.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.